Company advances its mission to deliver next-generation diabetes management solutions and expand global market penetration Next-generation column ...

Generation Bio, which once raised over $235 million from major investors like Fidelity and T. Rowe Price before going public ...

The global biotechnology market is projected to reach over $4 trillion by 2035; the GCC market is expected to reach $2.6 ...

Cooperation between African nations and China now growing to include AI, green energy and fintech, ambassador says during ...

Trinity Biotech’s next-generation system is designed to strengthen the company’s position in the global laboratory HbA1c market, which is currently estimated to be worth over $2 billion annually and ...

The Khalifa Centre for Genetic Engineering & Biotechnology (KCGEB) continues to drive the UAE’s leadership in genomics and biotechnology by transforming scientific knowledge into practical solutions ...

A new doctoral training centre based at Queen’s University Belfast will help to train the next generation of experts in ...

The Molecular Diagnostics - Infectious Disease market offers opportunities driven by multiplex testing, biotechnology advances, and rapid testing. Factors such as pathogen evolution, globalization, ...

Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct ...

OrganaBio opens up a new PBMC processing lab in the Greater San Francisco area to support rapid isolation of PBMCs from ...

New data analysis clarifies misleading benchmarks released by a competitor; separate SkylineDx analysis demonstrates Merlin CP-GEP Test provides stronger metastatic-risk stratification and superior ...

Trinity Biotech (TRIB) has secured regulatory clearances in multiple countries, enabling the expanded rollout of its next-generation high-capacity ...